Gnosis by Lesaffre proudly offers its clinically proven Vitamin K2 as MK-7, MenaQ7®, protected by its award-winning Matrix technology. Learn more in our new brochure!
Ensuring the stability of vitamin K2 compounds can be as complex as the finished product formulations that brand owners are conceiving – research shows that moisture and mineral salts are critical variables for degradation, driving the need for a protective technology to shelter the menaquinone molecules during shelf life.
Expertise is required to ensure the correct ingredient solution is provided depending on the final formulation and application. With more complex mineral formulations, the question is: how to protect that molecule through formulation and shelf life?
To that end, Gnosis by Lesaffre introduced its enhanced vitamin K2 protective technology – Vitamin K2 Matrix. This latest innovation is the result of a proprietary technology that protects the vitamin K2 as MK-7 molecule with no coating, no additives, and no additional ingredients, making it a true clean-label option, a sought-after quality for brand owners and consumers who demand to use ingredients with nutritional beneﬁts that are as close to their natural state as possible.
Gnosis by Lesaffre is now offering its premium, clinically validated MenaQ7Ò Vitamin K2 as MK-7 protected by this award-winning technology. Applying the Matrix protective technology to MenaQ7Ò ensures a smoother process for formulators to bring any product concept they can conceive to life. Still, more importantly, it ensures that consumers receive the clinically validated bone and heart benefits they rightfully expect.
A key attribute of Vitamin K2 Matrix is the versatility offered to formulators. The technology supports supplements in traditional formats, such as tablets and capsules, that combine K2 in synergistic formulations with complex minerals, as well as positioning Vitamin K2 in new delivery systems such as ready-to-drink applications like protein or milk powders. Regardless of your need, Matrix provides a less cumbersome and more predictable formulation process for complex product formats.
The technology is so groundbreaking that Nutrition Industry Executive recognized it with a First Place NIE Award for the Excipients/Non-Actives/Delivery Systems Category.
Gnosis by Lesaffre is now offering its premium, clinically validated MenaQ7® Vitamin K2 as MK-7 protected by this award-winning technology. As you will read in our new brochure, applying the Matrix protective technology to MenaQ7® ensures a smoother process for formulators to bring any product concept they can conceive to life, guaranteeing consumers receive the clinically validated bone and heart benefits they rightfully expect. Together let us develop game-changing products for your consumers.
Download our brochure to learn more : Download here